Patents by Inventor Sam Lin

Sam Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250115932
    Abstract: This invention generally relates to a novel induced cytoplasmic IVT (ICIVT) composition useful for inducing in-vitro transcription (IVT)-like RNA/mRNA amplification in the cells of interest after transfection in vitro, ex vivo and/or in vivo. The present invention is useful for designing and developing a variety of RNA/mRNA medicines as well as vaccines comprising a mixture of at least a promoter-linked RNA/mRNA-coding DNA (PLRcD) template and another DNA-dependent RNA polymerase (DdRP) mRNA sequence. Preferably, the DdRP mRNA may be selected from the mRNA of T7, T3 and/or SP6 RNA polymerase, or a combination thereof, while the PLRCD template may encode the transcripts of antisense RNA oligonucleotide (aRNA-ASO), small interferring RNA (siRNA), double-stranded RNA (dsRNA), short hairpin RNA (shRNA), microRNA (miRNA)/microRNA precursor (pre-miRNA), long noncoding RNA (lncRNA), messenger RNA (mRNA), and/or self-amplifying RNA/mRNA (saRNA/samRNA), or a combination thereof.
    Type: Application
    Filed: October 9, 2023
    Publication date: April 10, 2025
    Inventors: Shi-Lung LIN, Sam LIN, William HUNG, Hsien-Lin LIU, Yu-Jing WU
  • Publication number: 20250019709
    Abstract: This invention relates to a novel modified RNA composition (called oxo-RNA) comprising at least an oxo-nucleotide (containing oxopurine) in its 3?-end region (e.g. 3?-tail, 3?-UTR). The oxo-nucleotide includes 8-hydroxyguanine/8-oxoguanine/7,8-dihydro-8-oxoguanine (or called oxo-G/oxo-dG) and 8-hydroxyadenine/8-oxoadenine (or called oxo-A/oxo-dA). Oxo-RNA can be a single-stranded RNA sequence or double-stranded duplex, or even an RNA-DNA hybrid duplex. Advantageously, this new oxo-RNA composition not only greatly enhance RNA/DNA stability and functionality but also can prevent TREX1-mediated degradation and the related non-specific immunity over-activation (e.g. cytokine storm).
    Type: Application
    Filed: August 6, 2024
    Publication date: January 16, 2025
    Inventors: Shi-Lung LIN, Sam LIN, Wei-Chih HUNG, Hsien-Lin LIU, Yu-Jing WU
  • Publication number: 20250010267
    Abstract: A superabsorbent polymers and a method of forming the same are provided. The method is processed by adding calcined shell powders to a free radical polymerization. The superabsorbent polymers with more micropores can be obtained. Therefore, absorptivity and permeability for the liquid of the superabsorbent polymers are increased, and diffusibility and liquid conductivity of the superabsorbent polymers are also improved.
    Type: Application
    Filed: June 28, 2023
    Publication date: January 9, 2025
    Inventors: Zhong-Yi CHEN, Yu-Sam LIN, Ping-Chun CHENG
  • Publication number: 20240093286
    Abstract: This invention relates to a novel composition of RNA/mRNA medicines and/or vaccines produced by using Replicase/RNA-dependent RNA polymerase (RdRP)-mediated RNA Cycling Reaction (RCR). This RCR-amplifiable RNA/mRNA composition comprises at least a replicase/RdRP-binding site (RdRP-BS) in the 5?-end or 3?-end, or both, of a desired RNA sequence of interest, to form a self-amplifying RNA/mRNA (samRNA) platform. The samRNA platform so obtained is useful for designing and developing a variety of self-amplifying RNA/mRNA (samRNA) constructs, of which the desired RNA sequences may include, but not limited to, antisense oligonucleotide RNA (aRNA; ASO), small interfering RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNA)/miRNA precursor (pre-miRNA), long non-coding RNA (lncRNA), and/or messenger RNA (mRNA), or a combination thereof. The present RdRP-BS designs in said samRNA are derived or modified from the identified RdRP-BS motifs of coronavirus (e.g.
    Type: Application
    Filed: October 3, 2023
    Publication date: March 21, 2024
    Inventors: Shi-Lung LIN, Sam Lin
  • Publication number: 20230295627
    Abstract: This invention generally relates to a novel composition of RNA/mRNA medicines as well as vaccines produced by using replicase- and/or RNA-dependent RNA polymerase (RdRp)-mediated RNA cycling reaction (RCR). The present invention is useful for developing a variety of self-amplifying RNA/mRNA (samRNA) medicines and vaccines containing at least a replicase/RdRp-binding site in the 5?- or 3?-end, or both, of any desired RNA molecule, including but not limited to antisense RNA (aRNA), small interferring RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNA)/miRNA precursor, long non-coding RNA (lnRNA) and mRNA. These RNA molecules can be either in single-stranded or in double-stranded, or mixed, conformation. The samRNA so obtained is useful not only for producing RNA-based vaccines and/or medicines but also for generating the mRNA-associated proteins, peptides, and/or antibodies under a proper in-vitro or in-cell translation condition.
    Type: Application
    Filed: January 18, 2023
    Publication date: September 21, 2023
    Inventors: Shi-Lung Lin, Sam Lin, Chun-Hung Lin
  • Publication number: 20230242958
    Abstract: Disclosed herein is directed to a synthetic ribonucleic acid (RNA) fragment that includes an RNA template flanked by at least of 5?-end RNA-dependent RNA polymerase (RdRp) binding site and a 3?-end RdRp binding site, thus the synthetic RNA fragment can be amplified in vitro via an RNA-dependent RNA cycling reaction (RCR). Also disclosed herein is a method for producing an amplified RNA product by use of the present synthetic RNA fragment.
    Type: Application
    Filed: January 19, 2023
    Publication date: August 3, 2023
    Applicant: MELLO BIOTECH TAIWAN CO., LTD.
    Inventors: Shi-Lung LIN, Sam LIN, David TS WU
  • Publication number: 20230099592
    Abstract: This invention relates to a novel composition and method for RNA/mRNA production as well as amplification using viral RNA replicase and/or RNA-dependent RNA polymerase (RdRp) enzymes and the use of associated RNA/mRNA products thereof. The present invention can be used for manufacturing and amplifying all varieties of RNA/mRNA sequences carrying at least a replicase/RdRp-binding site in the 5?- or 3?-end, or both. The RNA/mRNA so obtained is useful for not only producing mRNA vaccines and/or RNA-based medicines but for generating the mRNA-associated proteins, peptides, and/or antibodies under an in-vitro as well as in-cell translation condition. Principally, the present invention is a novel RNA replicase/RdRp-mediated RNA/mRNA amplification method, namely Replicase Cycling Reaction (RCR). The RNA replicases involved in RCR include but not limited to viral and/or bacteriophage RNA-dependent RNA polymerases (RdRp) in either modified or non-modified mRNA and/or protein compositions, particularly coronaviral (e.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 30, 2023
    Inventors: Shi-Lung LIN, Sam Lin, Chun-Hung Lin
  • Publication number: 20230049825
    Abstract: A superabsorbent polymers and a method of forming the same are provided. The method is processed by adding calcined shell powders to a free radical polymerization. The superabsorbent polymers with more micropores can be obtained. Therefore, absorptivity and permeability for the liquid of the superabsorbent polymers are increased, and diffusibility and liquid conductivity of the superabsorbent polymers are also improved.
    Type: Application
    Filed: November 18, 2021
    Publication date: February 16, 2023
    Inventors: Zhong-Yi CHEN, Yu-Sam LIN, Ya-Chi LIN, Ping-Chung CHENG
  • Publication number: 20220411848
    Abstract: This invention generally relates to a novel RNA/mRNA production and amplification method using viral RNA replicase and/or RNA-dependent RNA polymerase (RdRp) enzymes as well as the associated mRNAs thereof. The present invention can be used for manufacturing and amplifying all varieties of RNA/mRNA sequences carrying at least an RdRp-binding site in the 5?- or 3?-end, or both. The RNA/mRNA so obtained is useful for not only producing mRNA vaccines and/or RNA-based medicines but also for generating the mRNA-associated proteins, peptides, and/or antibodies under an in-vitro as well as in-cell translation condition. Principally, the present invention is a novel RNA replicase-mediated RNA/mRNA amplification method, namely Replicase Cycling Reaction (RCR). The RNA replicases involved in RCR include but not limited to viral and/or bacteriophage RNA-dependent RNA polymerases (RdRp), particularly coronaviral and hepatitis C viral (HCV) RdRp enzymes.
    Type: Application
    Filed: January 19, 2022
    Publication date: December 29, 2022
    Inventors: Shi-Lung LIN, Sam LIN, Chun-Hung LIN
  • Publication number: 20220396778
    Abstract: This invention generally relates to a novel RNA composition and its production method useful for generating and expanding induced pluripotent stem cells (iPS cells; iPSC) as well as adult stem cells (ASC). The RNA composition so defined can be used for producing not only non-transgenic but also tumor-free iPS cells. The defined RNA composition contans at least two types of different RNA constructs; one is “miR-302 precursor RNA (pre-miR-302)” and the other is “RNA-dependent RNA polymerase (RdRp)” mRNA. Both of pre-miR-302 and RdRp mRNA contain highly structured RNA comformations, such as hairpin and stem-loop structures. To produce highly structured RNAs, a novel PCR-IVT methodology has been developed and used with a specially designed RNA polymerase-helicase mixture activity.
    Type: Application
    Filed: January 19, 2022
    Publication date: December 15, 2022
    Inventors: Shi-Lung LIN, Sam LIN, Chun-Hung LIN
  • Patent number: 10731024
    Abstract: A superabsorbent polymer includes polymer particles, surface cross-linking agents and particles made of silicon-containing inorganic salt. The polymer particles have cross-linking inside the polymer particles. The surface cross-linking agents are covalently bound to the surface of the polymer particles so as to constitute a surface cross-linked region at the surface of each said resin particle, and the particles made of silicon-containing inorganic salt cover the surface of the polymer particles.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: August 4, 2020
    Assignee: FORMOSA PLASTICS CORPORATION
    Inventors: Zhong-Yi Chen, Yu-Yen Chuang, Li-Han Huang, Yu-Sam Lin, Feng-Yi Chen, Ching-Hua Liang
  • Publication number: 20200050244
    Abstract: A detachable structure for shielding input/output (I/O) ports of a motherboard includes a housing and a blocking plate. The housing has a plurality of installed portions, an internal space, and an opening, the internal space communicates with the opening, and the plurality of installed portions are arranged in the internal space. The housing is arranged on the motherboard, and the internal space accommodates the I/O ports. The blocking plate is penetrated with a plurality of first holes. A plurality of installing elements are respectively fixed to the installed portions to fix the blocking plate to the housing, thereby shielding the opening. The positions of the plurality of first holes respectively correspond to the positions of the I/O ports to use the plurality of first holes to expose the I/O ports.
    Type: Application
    Filed: September 20, 2018
    Publication date: February 13, 2020
    Inventor: Sam LIN
  • Patent number: 10550243
    Abstract: A superabsorbent polymer includes polymeric particles, surface cross-linking agents and an extract of a plant of Sapindaceae. The polymeric particles have cross-linking inside the polymeric particles. The surface cross-linking agents are covalently bound to the surface of the polymeric particles so as to constitute a layer of surface cross-linked region at the surface of each polymeric particle, and the extract of the plant of Sapindaceae covers the surface of the polymeric particles.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: February 4, 2020
    Assignee: Formosa Plastics Corporation
    Inventors: Zhong-Yi Chen, Yu-Yen Chuang, Li-Han Huang, Yu-Sam Lin, Feng-Yi Chen, Ching-Hua Liang
  • Patent number: 10496140
    Abstract: A fixing device for an expansion card is installed on a frame of a desktop computer to fix an expansion card on the desktop computer. The fixing device includes at least two installation bases. After adjusting an interval between the installation bases, the installation bases are fixed to an opening of the frame by locking members. Each of the installation bases is provided with an installing through hole, such that an installation portion at the rear end of each of two fixing rods penetrates through the installing through. The front ends of the fixing rods vertically extend to form clamping portions to clamp the expansion card. The clamping portions and the expansion card are provided with a fixing batten to stabilize the expansion card.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: December 3, 2019
    Assignee: NZXT INC.
    Inventor: Sam Lin
  • Patent number: D910558
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: February 16, 2021
    Assignee: GUANGZHOU ROISKIN ELECTRICAL TECHNOLOGY CO., LTD.
    Inventor: Sam Lin
  • Patent number: D910559
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: February 16, 2021
    Assignee: GUANGZHOU ROISKIN ELECTRICAL TECHNOLOGY CO., LTD.
    Inventor: Sam Lin
  • Patent number: D913969
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: March 23, 2021
    Assignee: GUANGZHOU ROISKIN ELECTRICAL TECHNOLOGY CO., LTD.
    Inventor: Sam Lin
  • Patent number: D947830
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: April 5, 2022
    Assignee: Guangzhou Roiskin Technology Company
    Inventors: Sam Lin, Fanyiguo Cai
  • Patent number: D964983
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: September 27, 2022
    Assignee: Guangzhou Roiskin Electrical Technology Co., Ltd.
    Inventor: Sam Lin
  • Patent number: D973047
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: December 20, 2022
    Assignee: GUANGZHOU ROISKIN TECHNOLOGY COMPANY
    Inventor: Sam Lin